Eivind Jørgensen, one of Norway’s most experienced health economists, will take on the role of Associate Partner at Oslo Economics. Eivind has many years’ experience of consultancy services in health economic modelling and analysis, market access, and strategic advice to the pharmaceutical industry. Eivind also has worked in pharmaceutical and MedTech companies from across the Nordics. Eivind comes from the role of Managing Director of the consultancy firm Oecona in Norway and Sweden and will continue to serve these clients.
– Oslo Economics experience growth within health- and pharmacoeconomic analyses. We will take care of the trust we are given by our clients and with Eivind Jørgensen as an associated partner we will strengthen our expertise in the Nordic region (Erik Magnus Sæther, Partner at Oslo Economics).
Eivind will assume the role of Associate Partner at Oslo Economics from January 1, 2025. He will work as an integrated part of the team at Oslo Economics with a particular focus on health economic analyses, HTA support, and health registry-based research (“real-world evidence”).
– At Oecona, I have mainly worked with health economic analyses and method evaluations on behalf of pharmaceutical companies and other health technology providers. Oslo Economics has a strong professional environment in health and economic analyses, and I look forward to contributing to projects for various types of clients and applying my expertise to other issues within the health and care services (Eivind Jørgensen).
Attachment: Picture of Eivind Jørgensen retrieved from www.oecona.no
